Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) is an immune response largely mediated by natural killer (NK) cells that can lyse target cells and combat tumors and viral infections. However, the role of ADCC in response to primary HIV infection is poorly understood. In the present study, we explored the ADCC response and evaluated its characteristics in 85 HIV-infected individuals, including 42 with primary infections. Our results showed that ADCC occurs during acute infection, and the earliest ADCC response to a single peptide was detected at 52 days. Primary HIV-infected individuals exhibiting ADCC responses had lower viral set points than those with no ADCC response, and functional analyses demonstrated that the ADCC response could significantly inhibit viral infection during primary HIV infection. HIV epitopes that provoked the ADCC response were determined and three relatively conserved epitopes (HNVWATYACVPTDPNPQE, TSVIKQACPKISFDPIPI, and VVSTQLLLNGSLAEEEII) from the surface of the three-dimensional structure of the HIV Env protein were identified. Overall, our data indicate that ADCC responses may be significant for the control of HIV from an early stage during infection. These findings merit further investigation and will facilitate improvements in vaccines or therapeutic interventions against HIV infection.

Highlights

  • Human immunodeficiency virus (HIV) can infect CD4+ T cells [1] and cannot be efficiently cleared by the immune system [2]

  • The Antibody-dependent cell-mediated cytotoxicity (ADCC) response makes an important contribution to antiviral effects and may help to control HIV replication; the role of ADCC responses in primary HIV infection (PHI) requires further study

  • Our findings indicated that viral set points were significantly lower in subjects with positive, than in those with negative, ADCC responses

Read more

Summary

Introduction

Human immunodeficiency virus (HIV) can infect CD4+ T cells [1] and cannot be efficiently cleared by the immune system [2]. There are no sufficient medicines to cure HIV and no vaccine to prevent it. Thailand RV144, the only effective HIV vaccine, partially protects against HIV-1 (31%), possibly by stimulation of antibody-dependent cell-mediated cytotoxicity (ADCC) [3,4,5]. The ADCC immune response is largely mediated by natural killer (NK) cells. There is increasing evidence that ADCC response can influence the replication of HIV, and more robust ADCC responses are associated with slower disease progression and lower viral loads [7,8,9,10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call